These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 23255310)
1. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Aygun B; Mortier NA; Smeltzer MP; Shulkin BL; Hankins JS; Ware RE Am J Hematol; 2013 Feb; 88(2):116-9. PubMed ID: 23255310 [TBL] [Abstract][Full Text] [Related]
2. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Alvarez O; Miller ST; Wang WC; Luo Z; McCarville MB; Schwartz GJ; Thompson B; Howard T; Iyer RV; Rana SR; Rogers ZR; Sarnaik SA; Thornburg CD; Ware RE; Pediatr Blood Cancer; 2012 Oct; 59(4):668-74. PubMed ID: 22294512 [TBL] [Abstract][Full Text] [Related]
3. Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia. Yee ME; Lane PA; Archer DR; Joiner CH; Eckman JR; Guasch A Blood Cells Mol Dis; 2018 Mar; 69():65-70. PubMed ID: 28951038 [TBL] [Abstract][Full Text] [Related]
4. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Ware RE; Eggleston B; Redding-Lallinger R; Wang WC; Smith-Whitley K; Daeschner C; Gee B; Styles LA; Helms RW; Kinney TR; Ohene-Frempong K Blood; 2002 Jan; 99(1):10-4. PubMed ID: 11756146 [TBL] [Abstract][Full Text] [Related]
5. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922 [TBL] [Abstract][Full Text] [Related]
6. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. Brandow AM; Panepinto JA Am J Hematol; 2011 Sep; 86(9):804-6. PubMed ID: 21815183 [TBL] [Abstract][Full Text] [Related]
7. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Wang WC; Ware RE; Miller ST; Iyer RV; Casella JF; Minniti CP; Rana S; Thornburg CD; Rogers ZR; Kalpatthi RV; Barredo JC; Brown RC; Sarnaik SA; Howard TH; Wynn LW; Kutlar A; Armstrong FD; Files BA; Goldsmith JC; Waclawiw MA; Huang X; Thompson BW; Lancet; 2011 May; 377(9778):1663-72. PubMed ID: 21571150 [TBL] [Abstract][Full Text] [Related]
8. Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia. Dong M; McGann PT; Mizuno T; Ware RE; Vinks AA Br J Clin Pharmacol; 2016 Apr; 81(4):742-52. PubMed ID: 26615061 [TBL] [Abstract][Full Text] [Related]
9. Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent. Silva Junior GB; Vieira AP; Couto Bem AX; Alves MP; Meneses GC; Martins AM; Araújo SM; Libório AV; Daher EF Int J Clin Pharm; 2014 Aug; 36(4):766-70. PubMed ID: 24934760 [TBL] [Abstract][Full Text] [Related]
10. Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. Nottage KA; Ware RE; Winter B; Smeltzer M; Wang WC; Hankins JS; Dertinger SD; Shulkin B; Aygun B Eur J Haematol; 2014 Nov; 93(5):377-83. PubMed ID: 24796940 [TBL] [Abstract][Full Text] [Related]
11. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Fitzhugh CD; Wigfall DR; Ware RE Pediatr Blood Cancer; 2005 Dec; 45(7):982-5. PubMed ID: 15704213 [TBL] [Abstract][Full Text] [Related]
12. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Zimmerman SA; Schultz WH; Davis JS; Pickens CV; Mortier NA; Howard TA; Ware RE Blood; 2004 Mar; 103(6):2039-45. PubMed ID: 14630791 [TBL] [Abstract][Full Text] [Related]
13. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi. Mvalo T; Topazian H; Kamthunzi P; Chen J; Kambalame I; Mafunga P; Mumba N; Chiume-Chiphaliwali M; Paseli K; Key N; Gopal S; Hoffman I; Ataga K; Westmoreland K Blood Adv; 2018 Nov; 2(Suppl 1):30-32. PubMed ID: 30504195 [No Abstract] [Full Text] [Related]
14. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Aygun B; Mortier NA; Smeltzer MP; Hankins JS; Ware RE Pediatr Nephrol; 2011 Aug; 26(8):1285-90. PubMed ID: 21559933 [TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial. Aygun B; Lane A; Smart LR; Santos B; Tshilolo L; Williams TN; Olupot-Olupot P; Stuber SE; Tomlinson G; Latham T; Ware RE; Lancet Haematol; 2024 Jun; 11(6):e425-e435. PubMed ID: 38701812 [TBL] [Abstract][Full Text] [Related]
16. Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. Quinn CT; Niss O; Dong M; Pfeiffer A; Korpik J; Reynaud M; Bonar H; Kalfa TA; Smart LR; Malik P; Ware RE; Vinks AA; McGann PT Br J Haematol; 2021 Aug; 194(3):617-625. PubMed ID: 34227124 [TBL] [Abstract][Full Text] [Related]
17. Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia. McGann PT; Niss O; Dong M; Marahatta A; Howard TA; Mizuno T; Lane A; Kalfa TA; Malik P; Quinn CT; Ware RE; Vinks AA Am J Hematol; 2019 Aug; 94(8):871-879. PubMed ID: 31106898 [TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy for sickle cell anemia. McGann PT; Ware RE Expert Opin Drug Saf; 2015; 14(11):1749-58. PubMed ID: 26366626 [TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria. Ofakunrin AOD; Oguche S; Adekola K; Okpe ES; Afolaranmi TO; Diaku-Akinwumi IN; Zoakah AI; Sagay AS J Trop Pediatr; 2020 Jun; 66(3):290-298. PubMed ID: 31608959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]